Share chart Mainz Biomed N.V.
Extended chart
Simple chart
About Mainz Biomed N.V.
Mainz Biomed N.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics. It offers ColoAlert, a colorectal cancer screening stool-based deoxyribonucleic acid test; and PancAlert, a product candidate for a pancreatic cancer screening test. The company has a research collaboration with Microba Life Sciences to discover and develop novel therapeutics for major diseases. The company was founded in 2008 and is based in Mainz, Germany.| IPO date | 2021-11-05 |
|---|---|
| ISIN | NL0015000LC2 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://mainzbiomed.com |
| Цена ао | 4.73 |
| Change price per day: | -7.72% (4.73) |
|---|---|
| Change price per week: | -22.19% (5.61) |
| Change price per month: | -42.41% (7.58) |
| Change price per 3 month: | -18.56% (5.36) |
| Change price per half year: | +1 335.86% (0.304) |
| Change price per year: | +319.71% (1.04) |
| Change price per 3 year: | -68.12% (13.69) |
| Change price per 5 year: | 0% (4.365) |
| Change price per 10 year: | 0% (4.365) |
| Change price per year to date: | +1.04% (4.32) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| Institutions | Volume | Share, % |
|---|---|---|
| Prelude Capital Management LLC | 75000 | 0.43 |
| Citadel Advisors Llc | 33244 | 0.19 |
| Northern Trust Corporation | 33082 | 0.19 |
| Morgan Stanley | 32045 | 0.18 |
| Geode Capital Management, LLC | 15189 | 0.09 |
| Vontobel Holding Limited | 14000 | 0.08 |
| XTX Topco Ltd | 13850 | 0.08 |
| Greenwich Investment Management, Inc. | 13784 | 0.08 |
| NewEdge Advisors, LLC | 1000 | 0.01 |
| Citigroup Inc. | 673 | 0 |
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Mr. Guido Baechler | CEO & Executive Director | N/A | 1965 (60 years) |
| Mr. William J. Caragol | Chief Financial Officer | N/A | 1967 (58 years) |
| Dr. Frank Krieg-Schneider | Chief Technology Officer | N/A | 1962 (63 years) |
| Dr. Moritz Eidens Ph.D. | Chief Science Officer & Executive Director | N/A | 1984 (41 year) |
| Stefan Erlach | Head of Human Resources | N/A | |
| Mr. Philipp Freese | Chief Business Officer | N/A | 1983 (42 years) |
| Dr. Christopher Von Torne P.M.P., Ph.D. | Chief Operating Officer | N/A | 1972 (53 years) |
Address: Germany, Mainz, Robert Koch Strasse 50 - open in Google maps, open in Yandex maps
Website: https://mainzbiomed.com
Website: https://mainzbiomed.com
